Literature DB >> 5309739

[Symptomatic myasthenia in ocular myopathy].

A Prill, H J Meyer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5309739     DOI: 10.1007/BF00410483

Source DB:  PubMed          Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol        ISSN: 0065-6100


× No keyword cloud information.
  50 in total

1.  [Ocular myopathia. IV. Ocular myasthenia].

Authors:  E ESSLEN; H G MERTENS; W PAPST
Journal:  Nervenarzt       Date:  1959-08-20       Impact factor: 1.214

2.  [Ocular myopathies. II. Chronic ocular myositis].

Authors:  H G MERTENS; E ESSLEN; W PAPST
Journal:  Nervenarzt       Date:  1958-03-20       Impact factor: 1.214

3.  Electromyography; a tool in ocular and neurologic diagnosis. I. Myasthenia gravis.

Authors:  G M BREININ
Journal:  AMA Arch Ophthalmol       Date:  1957-02

4.  Prostigmine-responsiveness and the diagnosis of myasthenia gravis.

Authors:  L P ROWLAND
Journal:  Neurology       Date:  1955-09       Impact factor: 9.910

5.  [Myasthenic syndrome in polymyositis].

Authors:  M BONDUELLE; P BOUYGUES; J COULON
Journal:  Rev Neurol (Paris)       Date:  1955       Impact factor: 2.607

6.  Histological changes in the striped muscles in myasthenia gravis.

Authors:  D S RUSSELL
Journal:  J Pathol Bacteriol       Date:  1953-04

7.  [Neurogenic muscular atrophies, manifested during a predominantly ocular myasthenia gravis].

Authors:  H C Hopf; H P Ludin
Journal:  Nervenarzt       Date:  1968-09       Impact factor: 1.214

8.  Studies in myasthenia gravis: edrophonium chloride (tensilon) test as a new approach to management.

Authors:  K E OSSERMAN; L I KAPLAN; G BESSON
Journal:  J Mt Sinai Hosp N Y       Date:  1953 Sep-Oct

9.  Hyperthyroidism and myasthenia gravis.

Authors:  S SILVER; K E OSSERMAN
Journal:  J Mt Sinai Hosp N Y       Date:  1957 Nov-Dec

10.  [Chronic ocular myositis. II. Oligosymptomatic ocular myositis].

Authors:  W PAPST; H G MERTENS; E ESSLEN
Journal:  Klin Monbl Augenheilkd Augenarztl Fortbild       Date:  1959
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.